We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ask me anything on the chemistry of psilocybin featuring andrew wood
Webinar

Ask Me Anything: The Chemistry of Psilocybin

On-Demand
Join us for an exclusive Ask Me Anything (AMA) session with renowned chemist Andrew Wood as we delve into the fascinating world of psychedelics, focusing on the chemistry of psilocybin. This event will provide a unique opportunity to explore the scientific aspects of psilocybin, including its analytical approaches and mechanisms of action
bit.bio webinar technologynetworks 2nd May 2024
Webinar

Uncovering the Glioma Microenvironment With In Vitro Neuronal Models

On-Demand
In this webinar, you’ll hear from Dr. Brian Gill about his research into neuron–glioma interactions and how they contribute to seizures and tumoral growth.
Innovations in Disease Modeling 2024
Online Event

Innovations in Disease Modeling 2024

On-Demand
Explore the tools and techniques being used to study diseases in the lab. Discover how advances in cell culture and disease modeling are supporting diagnostic and therapeutic development.
Dr. Sam Clark will be presenting about novel salts and polymorphs of psilocybin at this Technology Networks webinar
Webinar

Breakthroughs in Psychedelic Chemistry: Discovering the World’s First Novel Salts and Polymorphs of Psilocybin, MDMA, LSD and Other Psychedelic Compounds

On-Demand
Join us on April 16 as we explore pioneering salts and polymorphs shaping the future of psychedelic therapeutics with expert speaker, Dr. Sam Clark, CEO and Founder of Terran Biosciences.
Immunoassay Technology
Webinar

Automated Immunoassay Technology for Efficient Biomarker Detection

On-Demand
This webinar explores a highly sensitive, automated assay workflow to provide high-quality results for low-abundance biomarkers in serum, plasma and cerebrospinal fluid.
TechNet MassSpec EdCal 25thJan2024
Webinar

Mass Spectrometry-Based Omics Strategies for Biomarker Discovery in Alzheimer’s Disease

On-Demand
Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.
Advertisement